| Compound |
Company |
Primary Therapeutical Area / Indication |
Drug development |
|
| Ragweed Tablet |
|
Immune System Diseases / Rhinitis, Allergic, Seasonal |
Phase I
|
 |
|
|
| EndoS |
|
Immune System Diseases / Lupus Erythematosus, Systemic |
Pre-clinical
|
 |
|
|
| FP219 |
|
Immune System Diseases |
Pre-clinical
|
 |
|
|
| FP237 |
|
Immune System Diseases |
Pre-clinical
|
 |
|
|
| FP289 |
|
Immune System Diseases |
Pre-clinical
|
 |
|
|
| IdeS |
|
Immune System Diseases / Graft vs Host Disease |
Pre-clinical
|
 |
|
|
| NZ39000 |
|
Immune System Diseases / Autoimmune Diseases |
Pre-clinical
|
 |
|
|
| Ph8 |
Phlogo
|
Immune System Diseases / Arthritis, Rheumatoid |
Pre-clinical
|
 |
|
|
| NeuroSTAT® |
NeuroVive Pharmaceutical AB
|
Injuries, Poisonings, and Occupational Conditions / Brain Hemorrhage, Traumatic |
Phase I
|
 |
|
|
| BP-C2 |
|
Injuries, Poisonings, and Occupational Conditions / Radiation Injuries |
Pre-clinical
|
 |
|
|
| Episil® |
|
Mouth and Tooth Diseases / Mucositis |
Phase IV
|
 |
|
|
| Calcitonin |
|
Muscle, Bone, and Cartilage Diseases / Osteoarthritis |
Phase III
|
 |
|
|
| SMC021 |
|
Muscle, Bone, and Cartilage Diseases / Osteoporosis |
Phase III
|
 |
|
|
| AMAP102 |
|
Muscle, Bone, and Cartilage Diseases / Osteoarthritis |
Phase II
|
 |
|
|
| ES 1 |
|
Muscle, Bone, and Cartilage Diseases / Osteoporosis |
Phase II
|
 |
|
|
| Huntexil® (pridopidine) |
|
Nervous System Diseases / Huntington Disease |
Phase III
|
 |
|
|
| I.V. Carbamazepine |
|
Nervous System Diseases / Epilepsy |
Phase III
|
 |
|
|
| FGL |
|
Nervous System Diseases / Alzheimer Disease |
Phase II
|
 |
|
|
| ABT-560 |
|
Nervous System Diseases / Central Nervous System Diseases |
Phase I
|
 |
|
|
| Egalet® Morphine PR |
|
Nervous System Diseases / Complex Regional Pain Syndromes |
Phase I
|
 |
|
|